Walleye Trading’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-3,200
Closed -$62.8K 4241
2024
Q2
$62.8K Sell
3,200
-5,400
-63% -$113K ﹤0.01% 3523
2024
Q1
$187K Buy
8,600
+5,900
+219% +$147K ﹤0.01% 3464
2023
Q4
$78.1K Buy
+2,700
New +$72.2K ﹤0.01% 4232
2023
Q3
Sell
-1,700
Closed -$63K 5099
2023
Q2
$63K Buy
1,700
+100
+6% +$3.49K ﹤0.01% 3897
2023
Q1
$50K Buy
+1,600
New +$51.5K ﹤0.01% 4075
2022
Q4
Sell
-9,100
Closed -$347K 5094
2022
Q3
$347K Buy
9,100
+4,600
+102% +$231K ﹤0.01% 3267
2022
Q2
$245K Buy
4,500
+1,500
+50% +$82.4K ﹤0.01% 3536
2022
Q1
$187K Sell
3,000
-3,200
-52% -$211K ﹤0.01% 3846
2021
Q4
$624K Buy
6,200
+500
+9% +$43.9K ﹤0.01% 2721
2021
Q3
$513K Sell
5,700
-300
-5% -$27.3K ﹤0.01% 2886
2021
Q2
$553K Buy
6,000
+2,200
+58% +$176K ﹤0.01% 2796
2021
Q1
$367K Buy
3,800
+2,200
+138% +$227K ﹤0.01% 3012
2020
Q4
$83K Buy
+1,600
New +$66.9K ﹤0.01% 4013

Other funds holding FLGT

Walleye Trading's FLGT Position: Q3 2024 in Review

Walleye Trading sold out of Fulgent Genetics (FLGT) in Q3 2024, closing a stake of 4,604 shares — an estimated $90.3K sold.

Walleye Trading first reported a position in FLGT in Q4 2020 and held it in 8 quarters. The position peaked at $353K in Q1 2021. 183 funds tracked by Wall St. Rank hold FLGT as of Q3 2024.

  • Walleye Trading reported no remaining Fulgent Genetics position as of Q3 2024 after selling out during the quarter.
  • Walleye Trading sold 4,604 Fulgent Genetics shares in Q3 2024, an estimated $90.3K.
  • Walleye Trading first reported a position in Fulgent Genetics in Q4 2020 and held it in 8 quarters.
  • Walleye Trading's Fulgent Genetics position peaked at $353K in Q1 2021.
  • 183 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2024.

Based on Walleye Trading's 13F filing for Q3 2024, filed 14 Nov 2024.